January 17th, local time, Brazil’s National Health Supervision Bureau announced that it would grant an emergency license to use the Kelifo coronavirus vaccine developed by China’s Kexing Company.
At the press conference held on the same day, Gustav Santos, head of the pharmaceutical and biological products department of the Brazilian Health Supervision Agency, and Fabricio Oliveira, the focal point of the pharmaceutical supervision department, detailed the development process, production process, storage conditions and the third phase of the Kellife coronavirus vaccine in Brazil.
Test results. Both experts said that the Kelif coronavirus vaccine is safe, effective and easy to store.
The panel of five experts, including Antonio Torres, director of the National Health Supervision Agency of Brazil, voted in favor of authorizing the emergency use of the Klaifou coronavirus vaccine.
In São Paulo, Brazil’s largest number of confirmed cases, 6 million doses of Kelifol coronavirus vaccine are now available for injection.
In addition, Brazilian Health Minister Eduardo Pazulo also announced on the same day that from 7:00 on January 18, the government will distribute coronavirus vaccines to all parts of the country and carry out full coronavirus vaccination activities at 10:00 on the 20th.
